Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: South Korea Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20091
20101
20112
20123
20132
20141
20182
20193
20232
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated7
Recruiting3
Active, not recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
AstraZeneca3
Eli Lilly and Company3
Novartis Pharmaceuticals3
Pfizer2
United Therapeutics2
Alnylam Pharmaceuticals1
Boehringer Ingelheim1
CSL Behring1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases25
Stroke8
Myocardial Infarction7
Diabetes Mellitus, Type 26
Atherosclerosis5
Hypertension5
Acute Coronary Syndrome4
Heart Diseases4
Vascular Diseases3
Connective Tissue Diseases2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.